Home
/
Treatment
/
(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl]...

(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide

	(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide
Trade Name
Orphan Indication	Pancreatic Cancer
USA Market Approval	USA
USA Designation Date	2011-03-18 00:00:00
Sponsor	NATCO Pharma Limited;Natco House;Hyderabad 500033

Related Access Program

Baxalta – Pancreatic Cancer University of Roma La Sapienza – Pancreatic Cancer University of Roma La Sapienza – Pancreatic Cancer